BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan L, Taber T, Kaushal S, Limgala R, Brown M, Gupta R, Balba N, Goker-Alpan O, Khojah A, Alpan O. A pilot study of omalizumab in eosinophilic esophagitis. PLoS One 2015;10:e0113483. [PMID: 25789989 DOI: 10.1371/journal.pone.0113483] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Lianto P, Zhang Y, Che H. Signals from the various immune cells in promoting food allergy-induced eosinophilic esophagitis like disease. Asia Pac Allergy 2019;9:e28. [PMID: 31384583 DOI: 10.5415/apallergy.2019.9.e28] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ko E, Chehade M. Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand? Clinic Rev Allerg Immunol 2018;55:205-16. [DOI: 10.1007/s12016-018-8674-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
3 Ghisa M, Laserra G, Maniero D, Marabotto E, Barberio B, Pelizzaro F, Barbuscio I, Zingone F, Savarino V, Savarino E. Eosinophilic esophagitis: from pathophysiology to management. Minerva Gastroenterol (Torino) 2022;68:40-8. [PMID: 33267562 DOI: 10.23736/S2724-5985.20.02780-4] [Reference Citation Analysis]
4 Hill DA, Spergel JM. The Immunologic Mechanisms of Eosinophilic Esophagitis. Curr Allergy Asthma Rep 2016;16:9. [PMID: 26758862 DOI: 10.1007/s11882-015-0592-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 5.5] [Reference Citation Analysis]
5 Durrani SR, Mukkada VA, Guilbert TW. Eosinophilic Esophagitis: an Important Comorbid Condition of Asthma? Clin Rev Allergy Immunol 2018;55:56-64. [PMID: 29455359 DOI: 10.1007/s12016-018-8670-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Provenzano E, Morrone P. Effective treatment with omalizumab of a patient with spontaneous chronic urticaria and eosinophilic esophagitis. J Dermatolog Treat 2018;29:5-7. [PMID: 30265608 DOI: 10.1080/09546634.2018.1527992] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Gómez-Aldana A, Jaramillo-Santos M, Delgado A, Jaramillo C, Lúquez-Mindiola A. Eosinophilic esophagitis: Current concepts in diagnosis and treatment. World J Gastroenterol 2019; 25(32): 4598-4613 [PMID: 31528089 DOI: 10.3748/wjg.v25.i32.4598] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
8 Ferguson AE, Mukkada VA, Fulkerson PC. Pediatric Eosinophilic Esophagitis Endotypes: Are We Closer to Predicting Treatment Response? Clin Rev Allergy Immunol 2018;55:43-55. [PMID: 29270819 DOI: 10.1007/s12016-017-8658-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Zhernov YV, Vysochanskaya SO, Sukhov VA, Zaostrovtseva OK, Gorshenin DS, Sidorova EA, Mitrokhin OV. Molecular Mechanisms of Eosinophilic Esophagitis. Int J Mol Sci 2021;22:13183. [PMID: 34947981 DOI: 10.3390/ijms222413183] [Reference Citation Analysis]
10 Choudhury S, Baker S. Eosinophilic Esophagitis: the Potential Role of Biologics in its Treatment. Clinic Rev Allerg Immunol 2020;59:150-9. [DOI: 10.1007/s12016-019-08749-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Vinit C, Dieme A, Courbage S, Dehaine C, Dufeu C, Jacquemot S, Lajus M, Montigny L, Payen E, Yang D, Dupont C. Eosinophilic esophagitis: Pathophysiology, diagnosis, and management. Archives de Pédiatrie 2019;26:182-90. [DOI: 10.1016/j.arcped.2019.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Mehr S, Brown-Whitehorn T. What do allergists in practice need to know about non-IgE-mediated food allergies. Ann Allergy Asthma Immunol 2019;122:589-97. [PMID: 30935977 DOI: 10.1016/j.anai.2019.03.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
13 Nhu QM, Aceves SS. Medical and dietary management of eosinophilic esophagitis. Ann Allergy Asthma Immunol 2018;121:156-61. [PMID: 29753831 DOI: 10.1016/j.anai.2018.05.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
14 Dowling PJ, Neuhaus H, Polk BI. The Role of the Environment in Eosinophilic Esophagitis. Clin Rev Allergy Immunol. 2018;. [PMID: 30032346 DOI: 10.1007/s12016-018-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Otani IM, Nadeau KC. Biologic Therapies for Immunoglobulin E-mediated Food Allergy and Eosinophilic Esophagitis. Immunol Allergy Clin North Am 2017;37:369-96. [PMID: 28366483 DOI: 10.1016/j.iac.2017.01.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Gonsalves NP, Aceves SS. Diagnosis and treatment of eosinophilic esophagitis. J Allergy Clin Immunol 2020;145:1-7. [PMID: 31910983 DOI: 10.1016/j.jaci.2019.11.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
17 Zhang S, Sicherer S, Berin MC, Agyemang A. Pathophysiology of Non-IgE-Mediated Food Allergy. Immunotargets Ther 2021;10:431-46. [PMID: 35004389 DOI: 10.2147/ITT.S284821] [Reference Citation Analysis]
18 Richter JE. Current Management of Eosinophilic Esophagitis 2015. J Clin Gastroenterol 2016;50:99-110. [PMID: 26485101 DOI: 10.1097/MCG.0000000000000430] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
19 Lepe M, O'Connell D, Lombardo KA, Herzlinger M, Mangray S, Resnick MB, Matoso A. The Inflammatory Milieu of Eosinophilic Esophagitis: A Contemporary Review With Emphasis in Putative Immunohistochemistry and Serologic Markers. Appl Immunohistochem Mol Morphol 2018;26:435-44. [PMID: 27801733 DOI: 10.1097/PAI.0000000000000450] [Reference Citation Analysis]
20 Cavalli E, Brusaferro A, Pieri ES, Cozzali R, Farinelli E, De' Angelis GL, Esposito S. Eosinophilic esophagitis in children: doubts and future perspectives. J Transl Med 2019;17:262. [PMID: 31399124 DOI: 10.1186/s12967-019-2014-0] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Hua S, Cook D, Walker MM, Talley NJ. Pharmacological treatment of eosinophilic gastrointestinal disorders. Expert Rev Clin Pharmacol. 2016;9:1195-1209. [PMID: 27191032 DOI: 10.1080/17512433.2016.1190268] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
22 Pandolfi F, Franza L, Altamura S, Mandolini C, Cianci R, Ansari A, Kurnick JT. Integrins: Integrating the Biology and Therapy of Cell-cell Interactions. Clin Ther 2017;39:2420-36. [PMID: 29203050 DOI: 10.1016/j.clinthera.2017.11.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
23 Chen JW. Management of Eosinophilic Esophagitis: Dietary and Nondietary Approaches. Nutr Clin Pract 2020;35:835-47. [PMID: 32822071 DOI: 10.1002/ncp.10571] [Reference Citation Analysis]
24 Camilleri AE, Nag S, Russo AR, Stiles KM, Crystal RG, Pagovich OE. Gene therapy for a murine model of eosinophilic esophagitis. Allergy 2021;76:2740-52. [PMID: 33748982 DOI: 10.1111/all.14822] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 McCormick JP, Lee JT. Insights into the Implications of Coexisting Type 2 Inflammatory Diseases. J Inflamm Res 2021;14:4259-66. [PMID: 34511966 DOI: 10.2147/JIR.S311640] [Reference Citation Analysis]
26 Racca F, Pellegatta G, Cataldo G, Vespa E, Carlani E, Pelaia C, Paoletti G, Messina MR, Nappi E, Canonica GW, Repici A, Heffler E. Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets. Front Physiol 2022;12:815842. [DOI: 10.3389/fphys.2021.815842] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Pelz BJ, Wechsler JB, Amsden K, Johnson K, Singh AM, Wershil BK, Kagalwalla AF, Bryce PJ. IgE-associated food allergy alters the presentation of paediatric eosinophilic esophagitis. Clin Exp Allergy 2016;46:1431-40. [PMID: 27388929 DOI: 10.1111/cea.12776] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
28 Incorvaia C, Mauro M, Makri E, Leo G, Ridolo E. Two decades with omalizumab: what we still have to learn. Biologics 2018;12:135-42. [PMID: 30464389 DOI: 10.2147/BTT.S180846] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
29 Kuang FL, Klion AD. Biologic Agents for the Treatment of Hypereosinophilic Syndromes. J Allergy Clin Immunol Pract 2017;5:1502-9. [PMID: 29122152 DOI: 10.1016/j.jaip.2017.08.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
30 Chawla K, Alabbas B, Sheth D, Papademetriou M. As Easy as EoE: A Novel and Effective Multidisciplinary Approach to Care of Patients with Eosinophilic Esophagitis in the Age of Biologics. Dig Dis Sci 2020;65:2196-202. [DOI: 10.1007/s10620-020-06366-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 de Rooij WE, Dellon ES, Parker CE, Feagan BG, Jairath V, Ma C, Bredenoord AJ. Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review. Drugs 2019;79:1419-34. [DOI: 10.1007/s40265-019-01173-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
32 Moawad FJ, Cheng E, Schoepfer A, Al-haddad S, Bellizzi AM, Dawson H, El-zimaity H, Guindi M, Penagini R, Safrooneva E, Chehade M. Eosinophilic esophagitis: current perspectives from diagnosis to management: Review on eosinophilic esophagitis. Ann N Y Acad Sci 2016;1380:204-17. [DOI: 10.1111/nyas.13164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Pesek RD, Gupta SK. Emerging drugs for eosinophilic esophagitis. Expert Opin Emerg Drugs. 2018;23:173-183. [PMID: 29848130 DOI: 10.1080/14728214.2018.1483335] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
34 Pesek RD, Gupta SK. Future therapies for eosinophilic gastrointestinal disorders. Ann Allergy Asthma Immunol 2020;124:219-26. [PMID: 31778820 DOI: 10.1016/j.anai.2019.11.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
35 Agache I, Cojanu C, Laculiceanu A, Rogozea L. Critical Points on the Use of Biologicals in Allergic Diseases and Asthma. Allergy Asthma Immunol Res 2020;12:24-41. [PMID: 31743962 DOI: 10.4168/aair.2020.12.1.24] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
36 Eke R, Li T, White A, Tariq T, Markowitz J, Lenov A. Systematic review of histological remission criteria in eosinophilic esophagitis. JGH Open 2018;2:158-65. [PMID: 30483582 DOI: 10.1002/jgh3.12059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
37 Sahiner UM, Layhadi JA, Golebski K, István Komlósi Z, Peng Y, Sekerel B, Durham SR, Brough H, Morita H, Akdis M, Turner P, Nadeau K, Spits H, Akdis C, Shamji MH. Innate lymphoid cells: The missing part of a puzzle in food allergy. Allergy 2021;76:2002-16. [PMID: 33583026 DOI: 10.1111/all.14776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
38 Capucilli P, Hill DA. Allergic Comorbidity in Eosinophilic Esophagitis: Mechanistic Relevance and Clinical Implications. Clin Rev Allergy Immunol 2019;57:111-27. [PMID: 30903437 DOI: 10.1007/s12016-019-08733-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
39 Chehade M, Aceves SS. Treatment of Eosinophilic Esophagitis: Diet or Medication? The Journal of Allergy and Clinical Immunology: In Practice 2021;9:3249-56. [DOI: 10.1016/j.jaip.2021.07.029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
40 Kumar S, Jeong Y, Ashraf MU, Bae YS. Dendritic Cell-Mediated Th2 Immunity and Immune Disorders. Int J Mol Sci 2019;20:E2159. [PMID: 31052382 DOI: 10.3390/ijms20092159] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
41 Rosenberg CE, Mingler MK, Caldwell JM, Collins MH, Fulkerson PC, Morris DW, Mukkada VA, Putnam PE, Shoda T, Wen T, Rothenberg ME. Esophageal IgG4 levels correlate with histopathologic and transcriptomic features in eosinophilic esophagitis. Allergy 2018;73:1892-901. [PMID: 29790577 DOI: 10.1111/all.13486] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
42 Wright BL, Spergel JM. Eosinophilic Esophagitis. J Allergy Clin Immunol Pract 2018;6:1799-801. [PMID: 30197073 DOI: 10.1016/j.jaip.2018.06.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Greuter T, Hirano I, Dellon ES. Emerging therapies for eosinophilic esophagitis. J Allergy Clin Immunol 2020;145:38-45. [PMID: 31705907 DOI: 10.1016/j.jaci.2019.10.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
44 Galdiero MR, Varricchi G, Seaf M, Marone G, Levi-Schaffer F, Marone G. Bidirectional Mast Cell-Eosinophil Interactions in Inflammatory Disorders and Cancer. Front Med (Lausanne) 2017;4:103. [PMID: 28791287 DOI: 10.3389/fmed.2017.00103] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 9.6] [Reference Citation Analysis]
45 Ferreira CT, Vieira MC, Furuta GT, Barros FCLF, Chehade M. Eosinophilic esophagitis-Where are we today? J Pediatr (Rio J) 2019;95:275-81. [PMID: 30075121 DOI: 10.1016/j.jped.2018.06.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
46 Olivieri B, Tinazzi E, Caminati M, Lunardi C. Biologics for the Treatment of Allergic Conditions: Eosinophil Disorders. Immunol Allergy Clin North Am 2020;40:649-65. [PMID: 33012326 DOI: 10.1016/j.iac.2020.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
47 Hon E, Gupta SK. Gastrointestinal Food Allergies and Intolerances. Gastroenterol Clin North Am 2021;50:41-57. [PMID: 33518168 DOI: 10.1016/j.gtc.2020.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Velikova T. Challenges and updates in the management of eosinophilic esophagitis. Prz Gastroenterol 2020;15:27-33. [PMID: 32215124 DOI: 10.5114/pg.2019.84476] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
49 Ruffner MA, Kennedy K, Cianferoni A. Pathophysiology of eosinophilic esophagitis: recent advances and their clinical implications. Expert Rev Clin Immunol 2019;15:83-95. [PMID: 30394139 DOI: 10.1080/1744666X.2019.1544893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
50 Fiocchi A, Vickery BP, Wood RA. The use of biologics in food allergy. Clin Exp Allergy 2021;51:1006-18. [PMID: 33966304 DOI: 10.1111/cea.13897] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, Falck-Ytter YT, Dellon ES; AGA Institute. Electronic address: clinicalpractice@gastro.org., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Electronic address: drdanawallace@gmail.com., AGA Institute., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters. Gastroenterology 2020;158:1789-1810.e15. [PMID: 32359563 DOI: 10.1053/j.gastro.2020.02.039] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
52 Ruffner MA, Spergel JM. Eosinophilic Esophagitis in Children. Curr Allergy Asthma Rep 2017;17:54. [PMID: 28653125 DOI: 10.1007/s11882-017-0721-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
53 Cardet JC, Casale TB. New insights into the utility of omalizumab. J Allergy Clin Immunol 2019;143:923-926.e1. [PMID: 30690050 DOI: 10.1016/j.jaci.2019.01.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
54 Ferguson AE, Fulkerson PC. Eosinophilic esophagitis: Time to classify into endotypes? J Allergy Clin Immunol 2018;142:71-2. [PMID: 29751005 DOI: 10.1016/j.jaci.2018.04.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
55 Arias Á, Lucendo AJ. Molecular basis and cellular mechanisms of eosinophilic esophagitis for the clinical practice. Expert Review of Gastroenterology & Hepatology 2018;13:99-117. [DOI: 10.1080/17474124.2019.1546120] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
56 Zhang S, Assa'ad AH. Biologics in eosinophilic esophagitis. Curr Opin Allergy Clin Immunol 2021;21:292-6. [PMID: 33769314 DOI: 10.1097/ACI.0000000000000741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Arasi S, Costa S, Magazzù G, Ieni A, Crisafulli G, Caminiti L, Chiera F, Vaccaro M, Del Giudice MM, Pajno GB. Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis. Ital J Pediatr 2016;42:32. [PMID: 27000314 DOI: 10.1186/s13052-016-0243-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
58 Cafone J, Ruffner MA, Spergel JM. The Role of Eosinophils in Immunotherapy. Curr Allergy Asthma Rep 2020;20:1. [PMID: 31912246 DOI: 10.1007/s11882-020-0895-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Stokes J. Anti-IgE Treatment for Disorders Other Than Asthma. Front Med (Lausanne) 2017;4:152. [PMID: 28983485 DOI: 10.3389/fmed.2017.00152] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
60 Carr S, Chan ES, Watson W. Correction to: Eosinophilic esophagitis. Allergy Asthma Clin Immunol 2019;15:22. [PMID: 31007687 DOI: 10.1186/s13223-019-0336-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Molina-Infante J, Gonzalez-Cordero PL, Arias A, Lucendo AJ. Update on dietary therapy for eosinophilic esophagitis in children and adults. Expert Rev Gastroenterol Hepatol 2017;11:115-23. [PMID: 27998193 DOI: 10.1080/17474124.2017.1271324] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
62 Lam AY, Ma C, Lee JK, Bredenoord AJ. Eosinophilic esophagitis: New molecules, better life? Curr Opin Pharmacol 2022;63:102183. [PMID: 35176546 DOI: 10.1016/j.coph.2022.102183] [Reference Citation Analysis]
63 Zdanowicz K, Kucharska M, Reszec J, Lebensztejn DM, Daniluk U. Immunohistochemical markers for eosinophilic esophagitis. Scand J Gastroenterol 2020;55:1277-83. [PMID: 33032462 DOI: 10.1080/00365521.2020.1831053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Dowling PJ, Neuhaus H, Polk BI. The Role of the Environment in Eosinophilic Esophagitis. Clin Rev Allergy Immunol 2019;57:330-9. [PMID: 30032346 DOI: 10.1007/s12016-018-8697-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
65 Letner D, Farris A, Khalili H, Garber J. Pollen-food allergy syndrome is a common allergic comorbidity in adults with eosinophilic esophagitis. Dis Esophagus 2018;31. [PMID: 29087472 DOI: 10.1093/dote/dox122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
66 Carr S, Chan ES, Watson W. Eosinophilic esophagitis. Allergy Asthma Clin Immunol 2018;14:58. [PMID: 30275848 DOI: 10.1186/s13223-018-0287-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
67 Williamson P, Aceves S. Allergies and Eosinophilic Esophagitis-Current Updates for the Pediatric Gastroenterologist. Curr Gastroenterol Rep 2019;21:56. [PMID: 31748971 DOI: 10.1007/s11894-019-0729-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
68 D'Auria E, Salvatore S, Pozzi E, Mantegazza C, Sartorio MUA, Pensabene L, Baldassarre ME, Agosti M, Vandenplas Y, Zuccotti G. Cow's Milk Allergy: Immunomodulation by Dietary Intervention. Nutrients 2019;11:E1399. [PMID: 31234330 DOI: 10.3390/nu11061399] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
69 Deleanu D, Nedelea I. Biological therapies for atopic dermatitis: An update. Exp Ther Med 2019;17:1061-7. [PMID: 30679974 DOI: 10.3892/etm.2018.6989] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
70 Simon D, Cianferoni A, Spergel JM, Aceves S, Holbreich M, Venter C, Rothenberg ME, Terreehorst I, Muraro A, Lucendo AJ, Schoepfer A, Straumann A, Simon HU. Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity. Allergy 2016;71:611-20. [PMID: 26799684 DOI: 10.1111/all.12846] [Cited by in Crossref: 128] [Cited by in F6Publishing: 105] [Article Influence: 21.3] [Reference Citation Analysis]
71 Gomez Torrijos E, Gonzalez-Mendiola R, Alvarado M, Avila R, Prieto-Garcia A, Valbuena T, Borja J, Infante S, Lopez MP, Marchan E, Prieto P, Moro M, Rosado A, Saiz V, Somoza ML, Uriel O, Vazquez A, Mur P, Poza-Guedes P, Bartra J. Eosinophilic Esophagitis: Review and Update. Front Med (Lausanne) 2018;5:247. [PMID: 30364207 DOI: 10.3389/fmed.2018.00247] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
72 Dispenza MC, Bochner BS. Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes. Curr Hematol Malig Rep 2018;13:191-201. [PMID: 29680938 DOI: 10.1007/s11899-018-0448-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
73 Rossi CM, Lenti MV, Merli S, Licari A, Votto M, Marseglia GL, Di Sabatino A. Primary eosinophilic gastrointestinal disorders and allergy: Clinical and therapeutic implications. Clin Transl Allergy 2022;12:e12146. [PMID: 35620572 DOI: 10.1002/clt2.12146] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Sallis BF, Erkert L, Moñino-Romero S, Acar U, Wu R, Konnikova L, Lexmond WS, Hamilton MJ, Dunn WA, Szepfalusi Z, Vanderhoof JA, Snapper SB, Turner JR, Goldsmith JD, Spencer LA, Nurko S, Fiebiger E. An algorithm for the classification of mRNA patterns in eosinophilic esophagitis: Integration of machine learning. J Allergy Clin Immunol 2018;141:1354-1364.e9. [PMID: 29273402 DOI: 10.1016/j.jaci.2017.11.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
75 . The role of eosinophils in immunotherapy. Curr Opin Allergy Clin Immunol 2020;20:329. [PMID: 31904620 DOI: 10.1097/ACI.0000000000000617] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Goyal A, Cheng E. Recent discoveries and emerging therapeutics in eosinophilic esophagitis. World J Gastrointest Pharmacol Ther 2016; 7(1): 21-32 [PMID: 26855809 DOI: 10.4292/wjgpt.v7.i1.21] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
77 Holm JG, Agner T, Sand C, Thomsen SF. Omalizumab for atopic dermatitis: case series and a systematic review of the literature. Int J Dermatol 2017;56:18-26. [DOI: 10.1111/ijd.13353] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
78 Eskian M, Khorasanizadeh M, Assa'ad AH, Rezaei N. Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis. Clin Rev Allergy Immunol. 2018;55:88-98. [PMID: 29234969 DOI: 10.1007/s12016-017-8659-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
79 Fiocchi A, Pecora V, Valluzzi RL, Fierro V, Mennini M. Use of biologics in severe food allergies. Curr Opin Allergy Clin Immunol 2017;17:232-8. [PMID: 28375933 DOI: 10.1097/ACI.0000000000000357] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
80 Rank MA, Sharaf RN, Furuta GT, Aceves SS, Greenhawt M, Spergel JM, Falck-Ytter YT, Dellon ES; AGA Institute. Electronic address: clinicalpractice@gastro.org., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Electronic address: drdanawallace@gmail.com., AGA Institute., Joint Task Force on Allergy-Immunology Practice Parameters collaborators. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters. Ann Allergy Asthma Immunol 2020;124:424-440.e17. [PMID: 32336463 DOI: 10.1016/j.anai.2020.03.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
81 Peterson MR, Coop CA. Long-term omalizumab use in the treatment of exercise-induced anaphylaxis. Allergy Rhinol (Providence) 2017;8:170-2. [PMID: 29070274 DOI: 10.2500/ar.2017.8.0204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]